Plain-English translation of NCT05794048 on ClinicalTrials.gov ↗ ·
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers are studying how liver cancer () and pancreatic tumors use energy and nutrients in ways that differ from normal cells. By examining tumor tissue samples from patients, the study aims to identify new markers that could help doctors better understand each patient's specific cancer and predict how it might behave. This knowledge could eventually lead to more personalized and effective treatment plans.
Currently, doctors don't have enough reliable ways to predict how these cancers will progress or which patients will benefit most from which treatments. Unlike breast cancer, where many such markers exist, liver and pancreatic cancer treatment is still based on fairly basic information. Understanding how these tumors reprogram their metabolism could reveal new clues to improve patient care.
If you enroll, you will have a tissue biopsy taken from your tumor during surgery or a medical procedure your doctor has already planned for you — the study does not require extra surgery. Researchers will analyze how your tumor cells use energy and nutrients, and this information will be linked with information about your cancer type and outlook. The main participation involves allowing the research team to study your tumor tissue samples; no long-term follow-up visits or medications are required by the study itself.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
France